TIAA CREF Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $892K | Hold |
174,921
| – | – | ﹤0.01% | 2378 |
|
|
2018
Q4 | $336K | Sell |
174,921
-78,895
| -31% | -$152K | ﹤0.01% | 2734 |
|
|
2018
Q3 | $959K | Sell |
253,816
-159,864
| -39% | -$604K | ﹤0.01% | 2437 |
|
|
2018
Q2 | $1.29M | Buy |
413,680
+58,353
| +16% | +$182K | ﹤0.01% | 2390 |
|
|
2018
Q1 | $849K | Buy |
355,327
+171,840
| +94% | +$411K | ﹤0.01% | 2515 |
|
|
2017
Q4 | $717K | Sell |
183,487
-7,786
| -4% | -$30.4K | ﹤0.01% | 2626 |
|
|
2017
Q3 | $482K | Hold |
191,273
| – | – | ﹤0.01% | 2842 |
|
|
2017
Q2 | $528K | Buy |
+191,273
| New | +$528K | ﹤0.01% | 2841 |
|
|
2016
Q2 | – | Sell |
-308,113
| Closed | -$360K | – | 3157 |
|
|
2016
Q1 | $360K | Buy |
308,113
+51,252
| +20% | +$59.9K | ﹤0.01% | 2875 |
|
|
2015
Q4 | $629K | Hold |
256,861
| – | – | ﹤0.01% | 2813 |
|
|
2015
Q3 | $771K | Buy |
256,861
+104,663
| +69% | +$314K | ﹤0.01% | 2722 |
|
|
2015
Q2 | $629K | Buy |
+152,198
| New | +$629K | ﹤0.01% | 2896 |
|